Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Do SGLT2 Inhibitors Benefit Everyone With T2D and CKD?
MADRID, Spain — Nearly half of people with type 2 diabetes (T2D) currently recommended to receive sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney protection would not actually benefit from them, new research suggests. Current guidelines recommend SGLT2 inhibitors for kidney…
English